DSIJ Mindshare

Jubilant Life Sciences has announced that its subsidiary Jubilant Pharma Limited has initiated Optimum trial, which is a pivotal Phase II clinical trial, designed to prove the safety and effectiveness of I-131 MIBG for the treatment of neuroblastoma. This will be taking place through Jubilant Pharma's unit Jubilant DraxImage Inc. in Montreal, Canada.

Sanwaria Consumer Limited's standalone revenue for the first quarter of fiscal year 2019 has marginally increased by 4 per cent to Rs. 1,200.14 crore on YoY basis. EBITDA for the quarter has increased by 45.8 per cent to Rs. 60.15 crore as compared to same quarter of previous fiscal year.

On the last day of subscription, the IPO of TCNS Clothing Company was oversubscribed 4.52 times on Friday, 20 July. The price band of the IPO is Rs. 714-716 per share of face value Rs. 2, with a lot size of 20 equity shares.

Auto Tyres and rubber tubes company, Ceat surged as much as 9.5 per cent in Friday’s trade on reporting Q1FY19 results. On Friday, the stock bounced back very sharply, breaching its two prior resistances at 1327 followed by 1351, supported by spurt in volumes and 14-period RSI crossing 55 levels.

Larson & Toubro Heavy Engineering have won prestigious orders of Rs. 1,600 crore which will be executed at L&T's fully integrated, advanced coastal manufacturing facility in Hazira, Gujarat. The stock has gained 2 per cent in the first half of trading session on Friday.